Uploaded on Aug 13, 2024
According to the latest research report by IMARC Group, The global digital PCR market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 9.25% during 2024-2032. More Info:- https://www.imarcgroup.com/digital-pcr-market
Digital PCR Market by Product Type, Distribution Channel, End User 2024-2032
Global Digital PCR
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
Accord ing t o the la tes t r epor t by I MARC G roup , t i t l ed "Dig i ta l PCR Market :
G loba l I ndust ry T rends , Share , S ize , Grow th , Opportun i ty and Forecast 2024-
2032, " t he g loba l d ig i t a l PCR marke t s i ze reached US$ 4 .7 B i l l i on in 2023.
Factors Af fect ing the Growth of the Dig i ta l PCR Industry:
Report Technologica l Advancements:
I nnovat ions in d ig i t a l PCR techno logy , i nc lud ing enhanced sens i t i v i t y , accu racy ,
Highlight and and mu l t i p lex ing capab i l i t i es , a re p rope l l i ng the marke t g rowt h . These improvemen t s con t i nua l l y r e f ine d ig i t a l PCR sys tems and enab le researchers and
c l in i c ians to ach ieve more prec ise and re l iab le resu l t s ac ross a d iverse range o f
Description app l i ca t ions .
Moreover , enhanced sens i t i v i t y a l lows f o r t he de tec t ion o f ra re mu ta t ions o r low-
abundance t a rge t s , wh i l e improved accu racy ensu res the va l i d i t y o f quan t i f i ca t ion
measurement s . Fur thermore , mu l t ip lex ing capab i l i t i es enab le s imu l taneous
de tec t ion and quant i f i ca t i on o f mu l t i p le t a rge ts w i th in a s i ng le samp le , enhanc ing
e f f i c iency and th roughpu t .
Rising Demand for Precision Medicine:
The increas ing focus on prec is ion medic ine is cata lyz ing the demand for
d ig i ta l PCR so lu t ions. The growing demand for accurate quant i f ica t ion and
analys is o f nuc le ic ac ids , a long wi th the r is ing need for personal ized
t reatment approaches, is o f fer ing a pos i t ive market out look.
Report In addi t ion, d ig i ta l PCR can prov ide absolu te quant i f i ca t ion wi thout
re l iance on s tandard curves that ensure prec ise measurement o f target
Highlight and deoxyr ibonucle ic ac id (DNA) or r ibonuc le ic ac id (RNA) molecu les. Th is
prec is ion is essent ia l for d iagnos ing d iseases, moni tor ing t reatment
Description responses, and gu id ing therapeut ic dec is ions ta i lored to ind iv idual pat ients.
Increasing Research Act ivi t ies:
Ris ing research act iv i t ies in genomics, t ranscr ip tomics, and molecu lar
b io logy are cont r ibut ing to the growth of the market . Addi t iona l ly , the
increasing need for robust and re l iab le technolog ies among researchers
exp lor ing the in t r icac ies o f the genome and t ranscr ip tome is impel l ing the
market growth.
Fur thermore , d ig i t a l PCR is su i tab le fo r gene express ion ana lys i s , de tec t ion o f
ra re muta t ions , and l i qu id b iopsy fo r advanced sc ien t i f i c unders tand ing and
med ica l b reak th roughs . Bes ides th is , t he ve rsa t i l i t y o f d ig i ta l PCR fac i l i t a tes
i t s in teg ra t ion in to va r ious research wo rk f lows , rang ing f rom bas ic research to
d rug deve lopment .
Report
Request for a PDF sample o f th is repor t :
Highlight and h t tps : / /www. imarcgroup .com/d ig i t a l -pc r -marke t / reques tsamp le
Description
Report Description
Global Digital PCR Market Trends:
Dig i ta l PCR of fers severa l advantages as compared to convent ional PCR techniques, such as h igher
sens i t iv i ty , absolu te quant i f ica t ion wi thout the need for standard curves, and improved
reproducib i l i ty . These advantages make d ig i ta l PCR an at t ract ive opt ion for researchers and
c l in ic ians.
Apar t f rom th is , government in i t ia t ives, research grants, and investments f rom pr ivate organizat ions
in genomics and molecu lar d iagnost ics are suppor t ing the development o f d ig i ta l PCR technology.
Th is f inancia l support cont r ibutes to market expansion by foster ing innovat ion and technolog ica l
advancements. In addi t ion, the r is ing awareness and acceptance among researchers and c l in ic ians
about d ig i ta l PCR is propel l ing the market growth.
View Report TOC, F igures and Tables : ht tps: / /www.imarcgroup.com/digita l -pcr-market
Breakup by Product Type:
• Digital PCR Equipment
• Consumables and Reagents
• Software and Services
Report Breakup by Technology:
• Droplet Digita l PCR
Segmentation • BEAMing Digita l PCR
Breakup by Application:
• Clinical Diagnostics
• Forensics
• Research
• Others
Breakup by Region:
• North America
Report • Asia-Pacifi c
Segmentation • Europe
• Latin America
• Middle East and Afr ica
• Avance Biosc iences Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• JN Medsys
Competitive • OPTOLANE Technologies Inc.
Landscape • QIAGEN
• SAGA Diagnost ics AB
with Key
• Standard BioTools Inc.
Players • Sti l la Technologies
• Sysmex Corporat ion
• Thermo Fisher Scient ifi c Inc.
How big is the global digital PCR market?
What is the expected growth rate of the global digital
PCR market during 2024-2032?
What are the key factors driving the global digital PCR
market?
Key
What has been the impact of COVID-19 on the global
Questions digital PCR market?
Answered in What is the breakup of the global digital PCR market based on the product type?
the Report What is the breakup of the global digital PCR market
based on the technology?
What is the breakup of the global digital PCR market
based on the application?
What are the key regions in the global digital PCR
market?
Who are the key players/companies in the global digital
PCR market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
2 . 4 . 1 B o t t o m - U p A p p r o a c h
Table of 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
4 . 1 O v e r v i e w
Contents 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l D i g i t a l P C R M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y P r o d u c t T y p e
6 . 1 D i g i t a l P C R E q u i p m e n t
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 C o n s u m a b l e s a n d R e a g e n t s
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 S o f t w a r e a n d S e r v i c e s
6 . 3 . 1 M a r k e t T r e n d s
6 . 3 . 2 M a r k e t F o r e c a s t
7 M a r k e t B r e a k u p b y T e c h n o l o g y
7 . 1 D r o p l e t D i g i t a l P C R
7 . 1 . 1 M a r k e t T r e n d s
7 . 1 . 2 M a r k e t F o r e c a s t
7 . 2 B E A M i n g D i g i t a l P C R
7 . 2 . 1 M a r k e t T r e n d s
7 . 2 . 2 M a r k e t F o r e c a s t
8 M a r k e t B r e a k u p b y A p p l i c a t i o n
8 . 1 C l i n i c a l D i a g n o s t i c s
8 . 1 . 1 M a r k e t T r e n d s
8 . 1 . 2 M a r k e t F o r e c a s t
8 . 2 F o r e n s i c s
8 . 2 . 1 M a r k e t T r e n d s
Table of 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 R e s e a r c h
8 . 3 . 1 M a r k e t T r e n d s
8 . 3 . 2 M a r k e t F o r e c a s t
Contents 8 . 4 O t h e r s 8 . 4 . 1 M a r k e t T r e n d s
8 . 4 . 2 M a r k e t F o r e c a s t
9 M a r k e t B r e a k u p b y R e g i o n
9 . 1 N o r t h A m e r i c a
9 . 1 . 1 U n i t e d S t a t e s
9 . 1 . 1 . 1 M a r k e t T r e n d s
9 . 1 . 1 . 2 M a r k e t F o r e c a s t
9 . 1 . 2 C a n a d a
9 . 1 . 2 . 1 M a r k e t T r e n d s
9 . 1 . 2 . 2 M a r k e t F o r e c a s t
9 . 2 A s i a - P a c i f i c
9 . 2 . 1 C h i n a
9 . 2 . 1 . 1 M a r k e t T r e n d s
9 . 2 . 1 . 2 M a r k e t F o r e c a s t
F o r m o r e i n f o r m a t i o n , v i s i t :
h t t p s : / / w w w. im a rcg ro u p . co m / d ig i t a l - pc r- m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments